NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market Wednesday that its fourth quarter revenues rose 32 percent year over year, driven by what it said were record numbers for both reproductive health test volume and revenues, and across-the-board increases in average revenue per test.

CombiMatrix reported total revenues of $3.5 million for the three months ended Dec. 31, 2016, compared to $2.7 million for the fourth quarter of 2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.